Recently Nature also reported the existence of a stem-like CD4+ T cells within TDLNs that are capable of differentiating into CD4+ TH1 cells and promoting effector differentiation of CD8+ T cells by secreting IFN-γ, thereby controlling tumor growth and improving response to ICI therapy [67]. This evidence concerns the gene CD4 and neoplasm.